LifeMD Financial Statements From 2010 to 2024

LFMD Stock  USD 6.36  0.02  0.32%   
LifeMD financial statements provide useful quarterly and yearly information to potential LifeMD Inc investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on LifeMD financial statements helps investors assess LifeMD's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting LifeMD's valuation are summarized below:
Gross Profit
100.4 M
Profit Margin
(0.12)
Market Capitalization
275.5 M
Enterprise Value Revenue
1.3624
Revenue
193.1 M
There are over one hundred nineteen available fundamental ratios for LifeMD, which can be analyzed over time and compared to other ratios. Investors should ensure to check all of LifeMD's last-minute performance against the performance from 2010 to 2024 to make sure the company is sustainable down the road. The current year's Market Cap is expected to grow to about 295.1 M. The current year's Enterprise Value is expected to grow to about 280.2 M

LifeMD Total Revenue

160.17 Million

Check LifeMD financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among LifeMD's main balance sheet or income statement drivers, such as Depreciation And Amortization of 6.9 M, Interest Expense of 2.7 M or Selling General Administrative of 54.3 M, as well as many indicators such as Price To Sales Ratio of 1.75, Dividend Yield of 0.0141 or PTB Ratio of 84.19. LifeMD financial statements analysis is a perfect complement when working with LifeMD Valuation or Volatility modules.
  
Check out the analysis of LifeMD Correlation against competitors.

LifeMD Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets61.4 M58.5 M14.6 M
Slightly volatile
Short and Long Term Debt Total19.9 M18.9 M3.2 M
Slightly volatile
Other Current Liabilities11.4 M10.8 M3.2 M
Slightly volatile
Total Current Liabilities36.5 M34.8 M9.9 M
Slightly volatile
Property Plant And Equipment Net678.9 K1.1 M436.2 K
Slightly volatile
Accounts Payable11.6 M11.1 M3.9 M
Slightly volatile
Cash34.8 M33.1 M8.3 M
Slightly volatile
Cash And Short Term Investments34.8 M33.1 M8.3 M
Slightly volatile
Net Receivables5.5 M5.3 M1.1 M
Slightly volatile
Common Stock Total Equity377.1 K362.9 K340.1 K
Slightly volatile
Common Stock Shares Outstanding35.6 M33.9 M14.4 M
Slightly volatile
Liabilities And Stockholders Equity61.4 M58.5 M14.6 M
Slightly volatile
Inventory2.9 M2.8 MM
Slightly volatile
Other Stockholder Equity228.3 M217.4 M64.1 M
Slightly volatile
Total Liabilities55.6 M52.9 M12.7 M
Slightly volatile
Property Plant And Equipment Gross678.9 K1.1 M436.2 K
Slightly volatile
Total Current Assets44.7 M42.6 M10.9 M
Slightly volatile
Short Term Debt903.8 K1.5 M737.7 K
Slightly volatile
Common Stock380.6 K383.6 K341.7 K
Slightly volatile
Short and Long Term Debt311.2 K327.6 K445.4 K
Slightly volatile
Other Liabilities1.2 M1.2 M642.7 K
Slightly volatile
Capital Stock364.5 K383.7 K1.2 M
Slightly volatile
Non Current Liabilities Other124.7 K131.2 K530.2 K
Pretty Stable
Intangible Assets15.5 M14.8 M3.8 M
Slightly volatile
Capital Lease Obligations903.9 K677 K352.2 K
Slightly volatile
Property Plant Equipment759.2 K547.9 K285.4 K
Slightly volatile
Warrants4.5 M5.3 M3.9 M
Slightly volatile
Capital Surpluse154.5 M205.9 M104 M
Slightly volatile
Preferred Stock Total Equity112126137
Slightly volatile
Other Assets0.80.90.98
Slightly volatile
Long Term Debt14.3 M16.1 M17.6 M
Slightly volatile

LifeMD Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization6.9 M6.6 M1.4 M
Slightly volatile
Interest Expense2.7 M2.6 M842.8 K
Slightly volatile
Selling General Administrative54.3 M51.7 M16.8 M
Slightly volatile
Total Revenue160.2 M152.5 M39.9 M
Slightly volatile
Gross Profit140.3 M133.6 M33.6 M
Slightly volatile
Other Operating Expenses175.4 M167 M52.6 M
Slightly volatile
Cost Of Revenue19.8 M18.9 M6.3 M
Slightly volatile
Total Operating Expenses155.9 M148.5 M46.4 M
Slightly volatile
Selling And Marketing Expenses80.3 M76.5 M25.1 M
Slightly volatile
Research Development6.4 M6.1 M1.2 M
Slightly volatile
Discontinued Operations1.1 M1.1 M539.8 K
Slightly volatile
Reconciled Depreciation6.2 M5.9 M1.3 M
Slightly volatile
Preferred Stock And Other Adjustments2.3 M2.8 M4.1 M
Slightly volatile
Non RecurringM3.4 M3.7 M
Slightly volatile

LifeMD Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation13.1 M12.5 M4.9 M
Slightly volatile
Depreciation6.9 M6.6 M1.3 M
Slightly volatile
End Period Cash Flow34.8 M33.1 M8.3 M
Slightly volatile
Begin Period Cash Flow5.2 MM4.1 M
Slightly volatile
Change To Netincome11.3 M20.6 M7.1 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.751.84253.8086
Slightly volatile
Dividend Yield0.01410.01110.0115
Slightly volatile
Days Sales Outstanding23.3312.626921.1296
Slightly volatile
Average Payables9.1 M8.6 M3.4 M
Slightly volatile
Stock Based Compensation To Revenue0.07780.08190.1843
Slightly volatile
Capex To Depreciation1.621.32321.1252
Slightly volatile
EV To Sales1.661.74943.7634
Slightly volatile
Inventory Turnover4.076.84824.954
Slightly volatile
Days Of Inventory On Hand50.6353.29998.178
Slightly volatile
Payables Turnover1.31.70511.5682
Pretty Stable
Sales General And Administrative To Revenue0.320.33890.8395
Slightly volatile
Average Inventory3.4 M3.2 M1.1 M
Slightly volatile
Research And Ddevelopement To Revenue0.04170.03970.0204
Slightly volatile
Capex To Revenue0.0360.05720.0245
Slightly volatile
Cash Per Share1.030.97760.3058
Slightly volatile
Days Payables Outstanding300214276
Slightly volatile
Intangibles To Total Assets0.190.25320.3151
Slightly volatile
Current Ratio0.861.22491.0061
Pretty Stable
Receivables Turnover34.4428.906540.9703
Slightly volatile
Graham Number1.061.18871.2426
Slightly volatile
Capex Per Share0.140.25760.0732
Slightly volatile
Average Receivables1.8 M1.7 M623.6 K
Slightly volatile
Revenue Per Share4.724.49921.5604
Slightly volatile
Interest Debt Per Share0.660.63280.1483
Slightly volatile
Debt To Assets0.230.32250.2391
Slightly volatile
Operating Cycle62.6365.9259119
Slightly volatile
Days Of Payables Outstanding300214276
Slightly volatile
Ebt Per Ebit0.771.20170.9454
Slightly volatile
Quick Ratio0.631.14560.7322
Slightly volatile
Net Income Per E B T0.741.18290.9194
Pretty Stable
Cash Ratio1.00.9530.5083
Slightly volatile
Days Of Inventory Outstanding50.6353.29998.178
Slightly volatile
Days Of Sales Outstanding23.3312.626921.1296
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.00940.00990.9829
Slightly volatile
Fixed Asset Turnover84.95142210
Pretty Stable
Debt Ratio0.230.32250.2391
Slightly volatile
Price Sales Ratio1.751.84253.8086
Slightly volatile
Asset Turnover2.562.60853.0914
Pretty Stable
Gross Profit Margin0.610.87610.7485
Pretty Stable

LifeMD Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap295.1 M281.1 M66.7 M
Slightly volatile
Enterprise Value280.2 M266.9 M61 M
Slightly volatile

LifeMD Fundamental Market Drivers

Forward Price Earnings27.6243
Cash And Short Term Investments33.1 M

LifeMD Upcoming Events

27th of March 2024
Upcoming Quarterly Report
View
10th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
27th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About LifeMD Financial Statements

LifeMD stakeholders use historical fundamental indicators, such as LifeMD's revenue or net income, to determine how well the company is positioned to perform in the future. Although LifeMD investors may analyze each financial statement separately, they are all interrelated. For example, changes in LifeMD's assets and liabilities are reflected in the revenues and expenses on LifeMD's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in LifeMD Inc. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue8.8 M9.3 M
Total Revenue152.5 M160.2 M
Cost Of Revenue18.9 M19.8 M
Stock Based Compensation To Revenue 0.08  0.08 
Sales General And Administrative To Revenue 0.34  0.32 
Research And Ddevelopement To Revenue 0.04  0.04 
Capex To Revenue 0.06  0.04 
Revenue Per Share 4.50  4.72 
Ebit Per Revenue(0.09)(0.10)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether LifeMD Inc is a strong investment it is important to analyze LifeMD's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact LifeMD's future performance. For an informed investment choice regarding LifeMD Stock, refer to the following important reports:
Check out the analysis of LifeMD Correlation against competitors.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of LifeMD. If investors know LifeMD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about LifeMD listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.64)
Revenue Per Share
4.847
Quarterly Revenue Growth
0.383
Return On Assets
(0.21)
Return On Equity
(7.82)
The market value of LifeMD Inc is measured differently than its book value, which is the value of LifeMD that is recorded on the company's balance sheet. Investors also form their own opinion of LifeMD's value that differs from its market value or its book value, called intrinsic value, which is LifeMD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because LifeMD's market value can be influenced by many factors that don't directly affect LifeMD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between LifeMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if LifeMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, LifeMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.